Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 8 studies | 28% ± 11% | |
| oligodendrocyte precursor cell | 6 studies | 24% ± 9% | |
| GABAergic neuron | 4 studies | 22% ± 5% | |
| oligodendrocyte | 4 studies | 20% ± 3% | |
| glutamatergic neuron | 3 studies | 38% ± 9% | |
| fibroblast | 3 studies | 18% ± 2% | |
| interneuron | 3 studies | 27% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1960.78 | 2640 / 2642 | 100% | 44.30 | 703 / 705 |
| ovary | 100% | 2424.94 | 180 / 180 | 92% | 13.37 | 396 / 430 |
| adrenal gland | 93% | 551.34 | 241 / 258 | 71% | 18.24 | 163 / 230 |
| uterus | 99% | 1365.61 | 169 / 170 | 30% | 4.07 | 137 / 459 |
| thymus | 85% | 401.67 | 554 / 653 | 43% | 2.73 | 261 / 605 |
| kidney | 93% | 565.84 | 83 / 89 | 34% | 2.91 | 310 / 901 |
| bladder | 100% | 699.24 | 21 / 21 | 25% | 2.01 | 127 / 504 |
| lung | 95% | 546.52 | 547 / 578 | 22% | 1.43 | 251 / 1155 |
| breast | 84% | 437.84 | 386 / 459 | 30% | 2.29 | 338 / 1118 |
| prostate | 100% | 915.06 | 244 / 245 | 8% | 0.71 | 40 / 502 |
| skin | 74% | 563.24 | 1347 / 1809 | 30% | 2.45 | 142 / 472 |
| spleen | 100% | 727.41 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 788.07 | 1307 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 86% | 649.78 | 833 / 966 | 7% | 0.42 | 39 / 527 |
| esophagus | 72% | 466.99 | 1036 / 1445 | 13% | 0.83 | 24 / 183 |
| adipose | 82% | 447.78 | 993 / 1204 | 0% | 0 | 0 / 0 |
| heart | 69% | 385.58 | 590 / 861 | 0% | 0 | 0 / 0 |
| stomach | 55% | 287.55 | 199 / 359 | 8% | 0.38 | 22 / 286 |
| pancreas | 5% | 17.57 | 15 / 328 | 48% | 3.61 | 85 / 178 |
| eye | 0% | 0 | 0 / 0 | 10% | 0.63 | 8 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.44 | 4 / 45 |
| liver | 1% | 5.35 | 3 / 226 | 2% | 0.13 | 10 / 406 |
| muscle | 2% | 6.67 | 15 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.74 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0097211 | Biological process | cellular response to gonadotropin-releasing hormone |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_2001223 | Biological process | negative regulation of neuron migration |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004968 | Molecular function | gonadotropin-releasing hormone receptor activity |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| Gene name | GPR173 |
| Protein name | G protein-coupled receptor 173 Probable G-protein coupled receptor 173 (Super conserved receptor expressed in brain 3) |
| Synonyms | SREB3 |
| Description | FUNCTION: Is a receptor for the SMIM20 derived peptides Phoenixin-14 and Phoenixin-20 (By similarity). It mediates the Phoenixin-14 and Phoenixin-20 augmentation of gonadotropin-releasing hormone (GNRH) signaling in the hypothalamus and pituitary gland (By similarity). In the ovary, it mediates the effects of Phoenixin-14 and Phoenixin-20 induced granulosa cell proliferation during follicular growth . . |
| Accessions | Q9NS66 J3KPD1 ENST00000332582.5 ENST00000375466.2 |
